My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 160

    1.

    Pharmacodynamic optimization of beta-lactams in the patient care setting.

    Nicolau DP.

    Crit Care. 2008;12 Suppl 4:S2. Epub 2008 May 21. Review.PMID: 18495059 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria.

    Moriyama B, Henning SA, Neuhauser MM, Danner RL, Walsh TJ.

    Ann Pharmacother. 2009 Jul;43(7):1324-37. Epub 2009 Jul 7. Review.PMID: 19584386 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Personalized optimization of beta-lactam regimens based on studies of the pharmacokinetics-pharmacodynamics at the target sites]

    Ikawa K.

    Yakugaku Zasshi. 2009 Jul;129(7):821-7. Review. Japanese. PMID: 19571517 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients.

    Rafati MR, Rouini MR, Mojtahedzadeh M, Najafi A, Tavakoli H, Gholami K, Fazeli MR.

    Int J Antimicrob Agents. 2006 Aug;28(2):122-7. Epub 2006 Jul 3.PMID: 16815689 [PubMed - indexed for MEDLINE]Related articles

    5.

    Continuous infusion of beta-lactam antibiotics.

    MacGowan AP, Bowker KE.

    Clin Pharmacokinet. 1998 Nov;35(5):391-402. Review.PMID: 9839090 [PubMed - indexed for MEDLINE]Related articles

    6.

    Is continuous infusion of beta-lactam antibiotics worthwhile?--efficacy and pharmacokinetic considerations.

    Mouton JW, Vinks AA.

    J Antimicrob Chemother. 1996 Jul;38(1):5-15. Review.PMID: 8858451 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Continuous infusion beta-lactams for intensive care unit pulmonary infections.

    Frei CR, Burgess DS.

    Clin Microbiol Infect. 2005 May;11(5):418-21.PMID: 15819874 [PubMed - indexed for MEDLINE]Related articles

    8.

    Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.

    Burgess DS.

    Chest. 1999 Mar;115(3 Suppl):19S-23S. Review.PMID: 10084455 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role.

    Roberts JA, Paratz J, Paratz E, Krueger WA, Lipman J.

    Int J Antimicrob Agents. 2007 Jul;30(1):11-8. Epub 2007 Apr 17. Review.PMID: 17442541 [PubMed - indexed for MEDLINE]Related articles

    10.

    Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.

    Adembri C, Fallani S, Cassetta MI, Arrigucci S, Ottaviano A, Pecile P, Mazzei T, De Gaudio R, Novelli A.

    Int J Antimicrob Agents. 2008 Feb;31(2):122-9. Epub 2007 Dec 4.PMID: 18055183 [PubMed - indexed for MEDLINE]Related articles

    11.

    Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.

    Burgess DS, Summers KK, Hardin TC.

    Clin Ther. 1999 Nov;21(11):1882-9.PMID: 10890260 [PubMed - indexed for MEDLINE]Related articles

    12.

    Optimizing use of beta-lactam antibiotics in the critically ill.

    Roberts JA, Lipman J.

    Semin Respir Crit Care Med. 2007 Dec;28(6):579-85. Review.PMID: 18095221 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pharmacokinetics in vivo and pharmacodynamics ex vivo/in vitro of meropenem and cefpirome in the Yucatan micropig model: continuous infusion versus intermittent injection.

    Elkhaïli H, Peter JD, Pompei D, Levless-Than-Or-Eq Slanteque D, Linger L, Salmon Y, Salmon J, Monteil H.

    Clin Microbiol Infect. 1998 Jan;4(1):18-26.PMID: 11864228 [PubMed - as supplied by publisher]Related articles

    14.

    The pharmacodynamics of beta-lactams.

    Turnidge JD.

    Clin Infect Dis. 1998 Jul;27(1):10-22. Review.PMID: 9675443 [PubMed - indexed for MEDLINE]Related articles

    15.

    A pharmacodynamic strategy to optimize empirical antibiotic therapy for gram-negative bacteria in a Brazilian Intensive Care Unit.

    Kiffer CR, Kuti JL, Mendes CM, Oplustil CP, Amarante JB, Biancalana ML, Xavier N, Nicolau DP.

    Braz J Infect Dis. 2007 Apr;11(2):183-5.PMID: 17625756 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen.

    Georges B, Conil JM, Cougot P, Decun JF, Archambaud M, Seguin T, Chabanon G, Virenque C, Houin G, Saivin S.

    Int J Clin Pharmacol Ther. 2005 Aug;43(8):360-9.PMID: 16119511 [PubMed - indexed for MEDLINE]Related articles

    17.

    Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children.

    Pichichero ME, Doern GV, Kuti JL, Nicolau DP.

    Paediatr Drugs. 2008;10(6):391-7. doi: 10.2165/0148581-200810060-00006.PMID: 18998749 [PubMed - indexed for MEDLINE]Related articles

    18.

    Optimizing bactericidal exposure for beta-lactams using prolonged and continuous infusions in the pediatric population.

    Courter JD, Kuti JL, Girotto JE, Nicolau DP.

    Pediatr Blood Cancer. 2009 Sep;53(3):379-85.PMID: 19422028 [PubMed - indexed for MEDLINE]Related articles

    19.

    Continuous infusion of beta-lactams.

    Mouton JW, Vinks AA.

    Curr Opin Crit Care. 2007 Oct;13(5):598-606. Review.PMID: 17762242 [PubMed - indexed for MEDLINE]Related articles

    20.

    Human pharmacodynamics of beta-lactams, aminoglycosides and their combination.

    Drusano GL.

    Scand J Infect Dis Suppl. 1990;74:235-48. Review.PMID: 2097712 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk